Elementis plc (LON:ELM) Receives GBX 186.67 Consensus Target Price from Analysts

Share on StockTwits

Shares of Elementis plc (LON:ELM) have been assigned an average rating of “Buy” from the six analysts that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is GBX 186.67 ($2.44).

A number of research firms recently weighed in on ELM. JPMorgan Chase & Co. reissued an “overweight” rating and set a GBX 195 ($2.55) price target on shares of Elementis in a research note on Monday, October 14th. Berenberg Bank dropped their price target on shares of Elementis from GBX 210 ($2.74) to GBX 200 ($2.61) and set a “buy” rating for the company in a research note on Friday, November 1st. Finally, UBS Group reissued a “buy” rating on shares of Elementis in a research note on Wednesday, November 20th.

Shares of ELM traded up GBX 2.60 ($0.03) on Monday, reaching GBX 170.70 ($2.23). 768,022 shares of the company’s stock were exchanged, compared to its average volume of 1,190,000. The company has a current ratio of 2.37, a quick ratio of 1.37 and a debt-to-equity ratio of 70.37. The stock has a market capitalization of $990.76 million and a P/E ratio of 19.62. The business has a 50 day moving average price of GBX 163.33 and a two-hundred day moving average price of GBX 148.45. Elementis has a 12 month low of GBX 127.30 ($1.66) and a 12 month high of GBX 200.80 ($2.62).

Elementis Company Profile

Elementis plc manufactures and sells specialty chemicals in North and South America, Europe, and Asia. It operates through Specialty Products and Chromium segments. The Specialty Products segment offers functional additives to the personal care, coatings, and energy end markets, as well as oilfield and construction sectors.

See Also: What is a conference call?

Analyst Recommendations for Elementis (LON:ELM)

Receive News & Ratings for Elementis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elementis and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Deutsche Bank Reaffirms “Sell” Rating for Antofagasta
Deutsche Bank Reaffirms “Sell” Rating for Antofagasta
AA  Earns Buy Rating from Citigroup
AA Earns Buy Rating from Citigroup
Crinetics Pharmaceuticals  Upgraded to “Hold” at Zacks Investment Research
Crinetics Pharmaceuticals Upgraded to “Hold” at Zacks Investment Research
Coherent  Upgraded at Zacks Investment Research
Coherent Upgraded at Zacks Investment Research
Camden Property Trust  Downgraded by Zacks Investment Research
Camden Property Trust Downgraded by Zacks Investment Research
Conifer  Downgraded to “Hold” at Zacks Investment Research
Conifer Downgraded to “Hold” at Zacks Investment Research


© 2006-2020 Ticker Report